Why the study?
Diagnostic and therapeutic tools significantly impact ACS morbidity and mortality, but data regarding ACS performance measures are scarce in Brazil.
Does higher adherence to evidence-based therapies (measured by a performance score) reduce in-hospital mortality in patients with acute coronary syndromes?
Population
1150 ACS patients from 72 hospitals in Brazil
Comparison
Performance score across institutions, including teaching vs non-teaching hospitals
Design
Cross-sectional observational epidemiological registry using stratified cluster sampling
Follow-up
In-hospital
Authors
Loading...
Supports performance scores for ACS quality monitoring in Brazil; hypothesis-generating for whether adherence interventions reduce mortality.
Does higher adherence to evidence-based therapies (measured by a performance score) reduce in-hospital mortality in patients with acute coronary syndromes?
Higher adherence to evidence-based therapies for ACS, as measured by a performance score, is independently associated with lower in-hospital mortality in Brazil.
Franken et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: